Tumor sections from sMEK1, paclitaxel, and sMEK1 plus paclitaxel-treated mice exhibited a 2.5–5 fold reduction in the number of blood vessels (Fig. 6B, lower panel). The gene discussed is PPP4R3A; the disease is neoplasm.